ScImage announced that it is delivering a fully customizable reporting and workflow documentation solution for vascular procedures. The reporting solution will be offered as an add-on to the company’s award winning Enterprise PACS solution, PicomEnterprise.
Toshiba America Medical Systems Inc. announced the introduction of its Infinix VF-i/SP X-ray system, a universal cardiovascular system designed to accommodate diagnostic and interventional procedures. The system will be showcased at the American College of Cardiology (ACC) annual meeting in New Orleans March 24-27, 2007.
GE Healthcare announced the availability of the latest version of Centricity Cardiology CA1000 version 2.0, which provides unique tools for analysis, segmentation, measurements, annotation, filming and exporting of clinically relevant images.
Siemens introduced the AXIOM Sensis XP - a new generation of integrated recording solutions that increases procedural efficiency, allowing for optimal patient care in the cath lab.
Cheetah Medical Inc., developers of the Cheetah NICOM system for non-invasive, real-time cardiac output monitoring, announced that an article entitled "Evaluation of a Noninvasive Continuous Cardiac Output Monitoring System Based on Thoracic Bioreactance" has been accepted for publication in the American Journal of Physiology, a leading journal in the field of cardiac physiology.
As the pioneer of metabolic assessment and behavioral therapy technologies, BodyMedia is developing tools that empower health professionals to better treat patients with chronic health conditions such as obesity, diabetes and cardiovascular disease (CVD).
Agfa HealthCare's Scheduling for Cardiology solution, a Web-enabled scheduling solution for resources management within cardiovascular departments, has been designed to be configurable to multiple, personal-based workflows. Scheduling for Cardiology’s Web-based architecture provides viewing and management of resource availability from any point of access to the hospital network.
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions.
The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.
Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.
